Clinical Trials
9 trialsNCT07124000 2026-05-01
DP-04
AstraZeneca
Recruiting
NCT05461430 2026-04-13
TraveraRTGx
Travera Inc
Completed
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT06776055 2025-01-15
Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women
Shanghai Zerun Biotechnology Co.,Ltd
Active not recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT02653118 2024-11-12
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
Merck Sharp & Dohme LLC
Active not recruiting
NCT03896958 2020-12-04
PIONEER
SpeciCare
Unknown
NCT00669422 2012-10-05
ChemoFx® PRO - A Post-Market Data Collection Study
Precision Therapeutics
Terminated